Wollenberg A, Cork M, Hong C-H, Kurbasic A, Vacko E, Paller A. Progressive and Sustained Disease Control in Patients with Atopic Dermatitis (AD) Aged 12–17 Years Treated with Tralokinumab for 52 Weeks. J of Skin [Internet]. 2024Mar.18 [cited 2024Sep.20];8(2):s377. Available from: https://dermsquared.com/skin/article/view/2680